PATENT CLAIM ANALYSIS

Application Number: 16075297
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "265100"]

Abstract:
The present invention relates to crystalline form A of a TLR7 agonist 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)-benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine (formula I), a method for preparing the crystalline form A, and the use thereof.

Claim (Index 6):
The preparing process according to  claim 4 , wherein in step 1), the amount of crystallizing solvent added per 1 g of the compound of formula I is 2 to 10 mL, preferably 4 to 8 mL, more preferably 5 to 7 mL.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 96.0
- Lexical Diversity: 1.29412
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16075303', '15772995', '16310369', '14976713', '15307525']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7212489180357925
- 35 USC 102 Novelty (BERT): 0.5279160701373
- Combined Prediction Score: 0.7019156332459432
- Mean Citation Score: 194.259596
- Max Citation Score: 253.80586
- Similarity Product: 137.00014928052423

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test